These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26498506)

  • 1. Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice.
    Madeo G; Schirinzi T; Maltese M; Martella G; Rapino C; Fezza F; Mastrangelo N; Bonsi P; Maccarrone M; Pisani A
    Neuropharmacology; 2016 Feb; 101():460-70. PubMed ID: 26498506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.
    Martella G; Platania P; Vita D; Sciamanna G; Cuomo D; Tassone A; Tscherter A; Kitada T; Bonsi P; Shen J; Pisani A
    Exp Neurol; 2009 Feb; 215(2):388-96. PubMed ID: 19071114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
    André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
    Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.
    Adermark L; Lovinger DM
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20564-9. PubMed ID: 18077376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
    Creed RB; Roberts RC; Farmer CB; McMahon LL; Goldberg MS
    Neurobiol Dis; 2021 Mar; 150():105246. PubMed ID: 33387634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice.
    Martella G; Madeo G; Maltese M; Vanni V; Puglisi F; Ferraro E; Schirinzi T; Valente EM; Bonanni L; Shen J; Mandolesi G; Mercuri NB; Bonsi P; Pisani A
    Neurobiol Dis; 2016 Jul; 91():21-36. PubMed ID: 26916954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
    J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models.
    Kreitzer AC; Malenka RC
    Nature; 2007 Feb; 445(7128):643-7. PubMed ID: 17287809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.
    Tebano MT; Martire A; Chiodi V; Pepponi R; Ferrante A; Domenici MR; Frank C; Chen JF; Ledent C; Popoli P
    J Neurochem; 2009 Sep; 110(6):1921-30. PubMed ID: 19627447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.
    Kreitzer AC; Malenka RC
    J Neurosci; 2005 Nov; 25(45):10537-45. PubMed ID: 16280591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus.
    Chiu CQ; Castillo PE
    Neuropharmacology; 2008 Jan; 54(1):68-78. PubMed ID: 17706254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.
    Madeo G; Schirinzi T; Martella G; Latagliata EC; Puglisi F; Shen J; Valente EM; Federici M; Mercuri NB; Puglisi-Allegra S; Bonsi P; Pisani A
    Mov Disord; 2014 Jan; 29(1):41-53. PubMed ID: 24167038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.
    Ronesi J; Gerdeman GL; Lovinger DM
    J Neurosci; 2004 Feb; 24(7):1673-9. PubMed ID: 14973237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling.
    Pan B; Hillard CJ; Liu QS
    J Neurosci; 2008 Dec; 28(52):14018-30. PubMed ID: 19109485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.
    Wu N; Cepeda C; Zhuang X; Levine MS
    J Neurophysiol; 2007 Jul; 98(1):423-32. PubMed ID: 17522168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum.
    De Chiara V; Motta C; Rossi S; Studer V; Barbieri F; Lauro D; Bernardi G; Centonze D
    Neuroscience; 2013 Oct; 250():232-9. PubMed ID: 23856068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
    Tozzi A; Durante V; Bastioli G; Mazzocchetti P; Novello S; Mechelli A; Morari M; Costa C; Mancini A; Di Filippo M; Calabresi P
    Neurobiol Dis; 2018 Oct; 118():1-8. PubMed ID: 29908325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.